Apteka Panaceumsp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-03-23
Share capital
5,000.00 PLN
Registered address
Daszyńskiego 65, 55-100 Trzebnica, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 38 days early.

  • 202510/07/2026
  • 202410/07/2025
  • 202314/06/2024
  • 202222/06/2023
  • 202112/05/2022
  • 202005/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 757.99kMedianUSD 129.70kAverageUSD 1.88m
Net profit
This companyUSD -15.69kMedianUSD 3.83kAverageUSD 76.36k
Operating costs
This companyUSD 763.24kMedianUSD 119.12kAverageUSD 1.78m
Assets
This companyUSD 293.24kMedianUSD 93.68kAverageUSD 903.51k

National Health Fund (NFZ) contracts

Apteka Panaceum has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesdolnośląskie1USD 0.00

Authorized Representatives

Magdalena Anna Malendowicz – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented independently by the President of the Management Board. In the case of a multi-member management board, the company is represented by two members of the management board or by one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
10$135.0610%
Magdalena Anna Malendowiczage 45
90$1,215.5690%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-04-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $15,605.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$8,805
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,955
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
Caifu Tradingsp. z o.o.
Fotsolsp. z o.o.
Business Energysp. z o.o.
Blauingsp. z o.o.
Construction Chemicalssp. z o.o.
HTS Tradingsp. z o.o.
THE Shire Cellarsp. z o.o.
EXPO Energysp. z o.o.
Nickovwaysp. z o.o.
Super Mega Tradesp. z o.o.

FAQ

Last updated: 2026-07-16